An initial panel of markers should be done to identify the lineage of tumor: carcinoma (cytokeratin AE1/3, OSCAR, CAM5.2), lymphoma (CD20, CD3), melanoma (S-100 protein, SOX10), and sarcoma (desmin, smooth muscle actin, MDM2, ERG). This evidence concerns the gene MDM2 and lymphoma.